Oncotype DX Breast Cancer Assay

Known as: Oncotype DX 
A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Oncotype DX (ODX) recurrence score (RS) breast cancer (BC) assay is costly, and performed in only ~1/3 of estrogen receptor (ER… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
PURPOSE Oncotype DX (ODX) is a tumor gene-profiling test that aids in adjuvant chemotherapy decision-making. ODX has the… (More)
Is this relevant?
2015
2015
Oncotype DX (Genomic Health, Redwood City, CA, USA, current list price $4,350.00) is a multigene quantitative reverse… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
This retrospective study evaluated the impact of intermediate Recurrence Score(®) results on adjuvant treatment decisions in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
INTRODUCTION The use of chemotherapy in node-negative, (O)Estrogen Receptor (ER)-positive breast cancer has changed significantly… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2011
2011
PURPOSE The Oncotype DX assay predicts likelihood of distant recurrence and improves patient selection for adjuvant chemotherapy… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Oncotype DXTM is an RT-PCR-based assay used to predict chemotherapy benefit in patients with estrogen receptor (ER) positive… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2010
2010
The use of clinicopathologic features in decision-making in early stage estrogen receptor (ER)-positive breast cancer (BC) may… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Novel genetic profiling tests of breast cancer tissue have been shown to be prognostic for overall survival and predictive of… (More)
  • table 1
  • figure 1
Is this relevant?
2006
2006
We now recognize that not all breast cancers are the same. Different characteristics in gene expression profiles result in… (More)
Is this relevant?